Skip to main content
. 2023 Jul 14;15(14):3621. doi: 10.3390/cancers15143621

Figure 1.

Figure 1

(A,B) patient number 2 photographed before starting treatment with Sonidegib 200 mg daily. (C,D) the same patient after 1 year of therapy. The complete remission of the locally advanced BCC was histologically confirmed, and Sonidegib was discontinued.